1 / 6

Africa Large Volume Parenterals (LVP) Market

The Africa large volume parenterals (LVP) market was valued at $662 million in 2017, and is expected to reach $1,133 million by 2024, growing at a CAGR of 7.9% from 2018 to 2024.

newmarketindustry
Download Presentation

Africa Large Volume Parenterals (LVP) Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Africa Large Volume Parenterals (LVP) Market

  2. The Africa large volume parenterals market is expected to grow significantly during the forecast period, owing to surge in demand for palliative care services throughout the country. Africa large volume parenterals (LVP) market was valued at $662 million in 2017, and is expected to reach $1,133 million by 2024, growing at a CAGR of 7.9% from 2018 to 2024. In terms of volume, the market garnered 291,095 thousand units in 2017, and is expected to reach 582,780 thousand units by 2024, growing with a CAGR of 10.4% from 2018 to 2024. Get Sample Report

  3. Parenteral route of drug administration refers to administration of drugs through non-oral routes. Large volume parenterals, also termed as large volume injections, are aqueous solutions usually supplied in volumes of at least 100 ml. They include calcium solutions, sodium chloride, ringer's, sodium bicarbonate and other electrolyte solutions, dextrose (glucose) & other sugar solutions, amino acid, peptide & other protein fraction solutions, solutions containing a combination of the above, sometimes with vitamins added, dextrans, and other plasma expanders.

  4. Increase in prevalence of chronic diseases, rapid surge in number of surgeries, and rise in risk of malnutrition are the major factors that drive the growth of the Africa large volume parenterals (LVP) market. However, preference for enteral nutrition and high risk of infection/allergic reaction during a parenteral administration restrain the market growth. Conversely, increase in demand for palliative care services in Africa is expected to offer potential growth opportunities for the market in the near future.

  5. Key Findings of the Africa Large Volume Parenterals Market: • Intramuscular segment is expected to grow with a CAGR of 8.2% from 2018 to 2024. • By treatment type, the nutritious injections segment is expected to grow at the highest CAGR of 9.1% from 2018 to 2024. • The 500 ml capacity segment held a major share of more than four-fifths and three-fourths in terms of value and volume, respectively, in 2017, and is expected to maintain this trend throughout the analysis period. • South Africa held a major share of more than one-fifth in the African market in 2017, and is expected to retain it throughout the analysis period. • Namibia is expected to register a CAGR of 7.7% from 2018 to 2024.

  6. The key local players within Africa large volume parenterals market include Abacus Parenteral Drugs Limited, Erongo Med, Datlabs Private Limited, Addis Pharmaceuticals Factory PLC, Pharmacure PLC, Mascareignes Pharmaceutical Manufacturing Co. Ltd. (operates as a subsidiary of Parenteral Drug (India) Ltd.), and Adcock Ingram Holdings Ltd.

More Related